CAGRILINTIDE 10mg

Description

Product Information

If you are looking to buy Cagrilintide peptide in the UK, VITALA’s Cagrilintide 10mg vial is one of the most precisely formulated research-grade options available from a domestic UK supplier today.

Cagrilintide is a long-acting synthetic analogue of amylin — a hormone naturally produced by the pancreas alongside insulin. While amylin itself has a very short half-life that limits its research utility, Cagrilintide has been engineered for extended duration of action, making it a far more practical and powerful tool for studying amylin receptor signalling over longer timeframes.

What makes Cagrilintide particularly exciting in current research is the role amylin plays in appetite regulation, glucose control, and metabolic balance. Amylin works in the brain — specifically in the hypothalamus and brainstem — to reduce food intake, slow gastric emptying, and support stable post-meal blood sugar levels. Cagrilintide replicates and extends these effects, giving researchers a uniquely durable compound for studying the central regulation of appetite and metabolic function.

Cagrilintide supports reduced appetite and food intake, improved blood glucose regulation, enhanced weight management, better metabolic balance, and slower gastric emptying. It has attracted significant research interest — particularly in the context of obesity and metabolic disease — and is widely regarded as one of the most promising compounds in contemporary cardiometabolic peptide research.

VITALA’s Cagrilintide 10mg vial gives UK researchers a stable, high-purity lyophilised compound that is consistent and reliable across a wide range of metabolic and endocrinological study protocols.

Research Focus

Cagrilintide has rapidly become one of the most talked-about peptides in metabolic and obesity research. Its long-acting amylin receptor activity, combined with growing interest in combination approaches to weight and glucose management, has placed it at the centre of some of the most active areas of peptide science today.

In UK laboratory settings, the VITALA Cagrilintide 10mg vial is currently being used to explore:

Appetite Regulation and Food Intake: Cagrilintide acts on amylin receptors in the hypothalamus and brainstem to reduce appetite and lower overall caloric intake. Researchers are studying the precise neurological pathways involved and how sustained amylin receptor activation influences hunger signalling over time.

Blood Glucose Regulation: Amylin plays an important complementary role to insulin in managing post-meal blood sugar levels. Studies are examining how Cagrilintide influences glucagon suppression, glucose absorption, and overall glycaemic control in metabolic research models.

Weight Management and Obesity Research: Cagrilintide has emerged as a significant compound in obesity research due to its ability to reduce food intake and support weight reduction through central appetite suppression. Researchers are investigating the magnitude, consistency, and durability of these effects across different study models.

Gastric Emptying and Satiety: One of amylin’s key physiological roles is slowing the rate at which food leaves the stomach, which prolongs feelings of fullness after eating. Studies are examining how Cagrilintide replicates and extends this effect and what this means for satiety signalling and eating behaviour in research models.

Cardiometabolic Health: Beyond appetite and glucose, researchers are studying Cagrilintide’s broader cardiometabolic effects — including its potential influence on lipid profiles, blood pressure, and cardiovascular risk markers in metabolic disease models.

Combination Research with GLP-1 Analogues: One of the most active areas of Cagrilintide research involves studying it alongside GLP-1 receptor agonists. The complementary mechanisms of amylin and GLP-1 pathways have generated significant scientific interest, with researchers exploring whether combined receptor activation produces synergistic improvements in weight and metabolic outcomes.

Central Nervous System Pathways: Cagrilintide acts centrally through the brain rather than purely on peripheral tissues. Researchers are mapping the specific hypothalamic and brainstem circuits involved in its appetite-suppressing effects and how these interact with other central metabolic regulators.

Composition of the Cagrilintide Research Vial

VITALA Cagrilintide is a single-compound research vial, giving researchers a clean and precisely dosed tool for studying this long-acting amylin analogue in isolation or as part of a broader combination research protocol.

Cagrilintide: 10mg — A long-acting synthetic analogue of human amylin, engineered with fatty acid acylation to extend its half-life and enable sustained amylin receptor activation over a significantly longer duration than native amylin allows. Cagrilintide acts centrally on amylin receptors in the hypothalamus and brainstem to reduce appetite, lower food intake, suppress post-meal glucagon release, slow gastric emptying, and support improved blood glucose regulation. It supports reduced appetite, better glucose control, enhanced weight management, improved metabolic balance, and prolonged satiety. Its durability and central mechanism of action make it one of the most valuable tools in contemporary metabolic and obesity research.

The compound is supplied as a lyophilised (freeze-dried) powder. It requires reconstitution with bacteriostatic water under sterile laboratory conditions before use. This format ensures peptide stability during transit and provides an extended shelf life when stored at the correct temperature.

Why Choose VITALA Cagrilintide from Peptide Shop UK

In metabolic research, the consistency of your compound directly affects the reliability of your data. Every VITALA Cagrilintide 10mg vial is independently tested and confirmed to a purity of greater than 98% using High-Performance Liquid Chromatography (HPLC). That means every vial you receive meets the same exacting standard — giving you data you can trust, study after study.

Each vial is sealed under sterile manufacturing conditions, protecting the peptide from contamination before it reaches your laboratory. Whether you are running a standalone Cagrilintide study or incorporating it into a broader combination research protocol, you get the same verified quality and consistency every time.

For UK researchers who need to buy Cagrilintide peptide from a reliable domestic source, Peptide Shop UK offers fast tracked delivery, transparent purity verification, and a research-grade product range designed around the needs of the UK scientific community.

Product Specifications

Product Name: Cagrilintide Format: Lyophilised Powder – Injectable Vial Total Peptide Content: 10mg Purity: >98% (HPLC Verified) Reconstitution: Bacteriostatic Water Required Intended Use: Research & Development Only

Storage and Laboratory Handling

Storing your Cagrilintide vial correctly is straightforward. Before reconstitution, keep the vial refrigerated at between 2°C and 8°C and away from direct sunlight. Do not freeze the lyophilised powder as this can compromise the structural integrity of the peptide.

Once reconstituted with bacteriostatic water, store the solution in the refrigerator and use it within the recommended stability window for bacteriostatic peptide preparations. Always replace the cap securely after each laboratory use to maintain a sterile environment and protect the remaining compound.

Regulatory Status in the UK

Cagrilintide is sold strictly for Research and Development (R&D) use within the United Kingdom. It is not a licensed medicinal product and is not approved for human consumption or clinical administration. All research involving this compound must be conducted within a registered laboratory setting and in full compliance with applicable UK regulations.

Who Is This Product For

VITALA Cagrilintide 10mg is intended for UK-based endocrinologists, metabolic researchers, biochemists, and qualified laboratory professionals actively working in the fields of obesity research, cardiometabolic science, appetite regulation, glucose metabolism, and peptide pharmacology. It is not suitable for personal use or self-administration.

Shipping and Delivery

All VITALA orders placed through Peptide Shop UK are dispatched domestically via Royal Mail Tracked Delivery. Your vials are carefully packaged to protect lyophilised compounds throughout the delivery journey. Most UK orders arrive within 2 to 4 working days from the date of dispatch — keeping your research on schedule without unnecessary delays.

All peptides sold by Peptide Shop UK under the VITALA brand are intended for Research and Development (R&D) purposes only.